Tomas Kiselak's Net Worth
$0
Who is Tomas Kiselak?
Tomas Kiselak does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Apogee Therapeutics, Inc., Viridian Therapeutics, Inc.\DE, Spyre Therapeutics, Inc., Dianthus Therapeutics, Inc. /DE/, and Oruka Therapeutics, Inc..
SEC CIK
Tomas Kiselak's CIK is 0001830177
Past Insider Trading and Trends
2021 was Tomas Kiselak's most active year for acquiring shares with 2 total transactions. Tomas Kiselak's most active month to acquire stocks was the month of January. 2021 saw Tomas Kiselak paying a total of $0.00 for 37,500 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Apogee Therapeutics, Inc. (APGE) Snapshot price: $47.25
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
| 2.05M |
Mar 28
| |||
Form 4
| -88.53% | -790.20K |
—
|
—
| 102.33K |
Scheduled
|
Jan 29
| ||
Form 4
|
∞
| 2.94M |
$17.00 | $49,999,992.00 | 2.94M |
Jul 13
| |||
| No matching records found | |||||||||
Spyre Therapeutics, Inc. (AGLE) No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 4
| +961.81% | 3.64M |
—
|
—
| 4.02M |
Apr 25
| |||
Form 4
| -76.36% | -2.62M |
—
|
—
| 812.08K |
Dec 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 7
| |||
Form 4
|
∞
| 3.44M |
—
|
—
| 3.44M |
Nov 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Dianthus Therapeutics, Inc. /DE/ (DNTH) Snapshot price: $26.62
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
| 2.7M |
Apr 1
| |||
Form 4
| +43.26% | 834.33K |
$12.00 | $10,012,008.00 | 2.76M |
Jan 22
| |||
Form 4
| +1.30% | 24.67K |
$13.63 | $336,252.10 | 1.93M |
Sep 29
| |||
Form 4
| +1.60% | 30K |
$13.15 | $394,500.00 | 1.9M |
Sep 26
| |||
Form 4
| +1.63% | 30K |
$13.20 | $396,000.00 | 1.87M |
Sep 19
| |||
Form 4
| +1.33% | 24.25K |
$11.20 | $271,679.87 | 1.84M |
Sep 11 - Sep 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Oruka Therapeutics, Inc. (ORKA) No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +75.63% | 275K |
$23.00 | $6,325,000.00 | 638.61K |
Sep 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Zenas BioPharma, Inc. (ZBIO) No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| +557.42% | 1.6M |
$17.00 |
—
| 1.89M |
Sep 12 - Sep 16
| |||
Form 4
| +3,901.05% | 1.6M |
$17.00 |
—
| 1.65M |
Sep 12 - Sep 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||